Dr. Tim Vogel's Pioneering Work in Pediatric Neuro-Oncology Research

“To continue advancing our understanding of and ability to treat neuro-oncologic issues, we need to build a pipeline from research to clinical applications,” said Dr. Vogel. “Dr. Hanson and I plan to explore treatments for rare brain tumors, specifically embryonal tumors with multilayered rosettes. These exceptionally aggressive tumors usually affect children younger than 4 years of age, with an average survival rate of 6 months to 1 year following diagnosis. I see it as my responsibility to help advance our medical knowledge of these potentially devastating diseases as much as possible, and I feel privileged to touch the lives of every pediatric patient who requires care.”